US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Auryxia

Reason cGMP deviations: Lots recalled were not manufactured in conformance with the FDA-approved manufacturing process for Auryxia.

Keryx Biopharmaceuticals, Inc. D-1389-2020
Class II · Moderate risk Terminated

Shine & Clean Hand Sanitizer gel

Reason CGMP Deviations: Products manufactured at the same site were FDA testing found below the label claim for ethanol content and the presence of undeclared methanol.

Maquiladora Miniara Sa De Cv NDC 76753-001-01 D-1565-2020
Class I · High risk Terminated

Daptomycin for Injection

Reason Presence of Particulate Matter

Mylan Institutional LLC NDC 67457-813-50 D-1484-2020
Class I · High risk Terminated

BD ChloraPrep Hi-Lite Orange 2% w/v chlorhexidine gluconate

Reason Non-sterility: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

CareFusion 213, LLC NDC 54365-400-33 D-0268-2021
Class I · High risk Terminated

ChloraPrep One-Step 2% w/v chlorhexidine gluconate

Reason Microbial Contamination of Non-Sterile Product: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

CareFusion 213, LLC D-0267-2021
Class I · High risk Terminated

ChloraPrep With Tint 2% w/v chlorhexidine gluconate

Reason Microbial Contamination of Non-Sterile Products:Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

CareFusion 213, LLC D-0266-2021
Class I · High risk Terminated

BD ChloraPrep Clear

Reason Non-sterility: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

CareFusion 213, LLC NDC 54365-400-32 D-0265-2021
Class III · Low risk Terminated

Clonazepam Orally Disintegrating Tablets

Reason Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine

Sun Pharmaceutical Industries INC NDC 57664-783-86 D-1445-2020
Class III · Low risk Terminated

Skin Medica Acne System

Reason SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.

Allergan PLC D-1410-2020
Class III · Low risk Terminated

Skin Medica Acne Treatment Lotion

Reason SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.

Allergan PLC NDC 0023-4965-02 D-1409-2020
Class II · Moderate risk Terminated

Vancomycin HCL 1.5 mg Edge Pharma

Reason Labeling: Label Error on Declared Strength

Edge Pharma, LLC NDC 05446-1458-01 D-1562-2020
Class II · Moderate risk Terminated

Yohimbine HCL 5.4mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1443-2020
Class II · Moderate risk Terminated

Vardenafil 20 mg Troche

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1442-2020
Class II · Moderate risk Terminated

Testosterone/Anastrozole Pellet 100/6 mg

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1441-2020
Class II · Moderate risk Terminated

Tadalafil 7 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1440-2020
Class II · Moderate risk Terminated

Tadalafil 3 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1439-2020
Class II · Moderate risk Terminated

Tadalafil 26 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1438-2020
Class II · Moderate risk Terminated

Tadalafil 18 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1437-2020
Class II · Moderate risk Terminated

Tadalafil 12 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1436-2020